Can Saxenda (Liraglutide) Cause Tinnitus?
Medically reviewed by Veronica Hackethal | MD, MSc, Harvard University | University of Oxford | Columbia Vagelos College of Physicians and Surgeons on July 21st, 2026.
Published on July 16th, 2026. Updated on July 22nd, 2026.
Key takeaways
Tinnitus is not a confirmed Saxenda side effect, but a small number of reports exist in pharmacovigilance databases like the FDA's FAERS system.
GLP-1 receptors found in inner ear tissue create a biologically plausible pathway, even though causation has not been established at a population level.
People taking liraglutide often have other independent tinnitus risk factors, including hypertension, type 2 diabetes, and obesity, which complicates attribution.
The most practical clue for patients and clinicians is timing: whether tinnitus began within days to weeks of starting or increasing liraglutide.
Always report new tinnitus to your prescribing provider rather than stopping liraglutide on your own, since abrupt discontinuation carries its own risks.
What the Clinical Data Actually Says About Liraglutide and Tinnitus
If you started taking Saxenda or Victoza and then noticed a ringing or buzzing in your ears, you are probably wondering whether the medication is to blame. The honest answer is that tinnitus is not listed as a common or established side effect in the official prescribing information for either liraglutide product. That said, the FDA's Adverse Event Reporting System (FAERS) does contain a small number of tinnitus reports tied to liraglutide use.
The volume of those reports is low compared to the millions of people who have used the medication, and low report counts do not confirm a causal link. What they do signal is that some patients experience tinnitus while on liraglutide, and the overlap is worth taking seriously rather than brushing aside. Absence from official labeling means causation has not been confirmed at a population level. It does not mean rare individual reactions are impossible.
How GLP-1 Receptors Interact with the Inner Ear
One reason clinicians and researchers do not immediately dismiss a possible liraglutide-tinnitus connection is biology. GLP-1 receptors are not confined to the pancreas. They appear in tissues throughout the body, including the brain and structures of the inner ear. That distribution raises legitimate questions about biological plausibility.
Liraglutide also influences blood pressure and fluid balance. Both of those factors can affect inner ear pressure and auditory function. Shifts in endolymphatic fluid, for example, are already understood to contribute to tinnitus in conditions like Meniere's disease. Whether liraglutide's effects on fluid regulation could produce similar pressures in susceptible individuals is not yet fully understood.
Additionally, the rapid weight loss that liraglutide can produce sometimes changes how the Eustachian tube functions. In some people, significant weight loss causes the Eustachian tube to open too easily, a condition called patulous Eustachian tube, which can produce ear symptoms including a sense of fullness, autophony, and occasional ringing.
Understanding Side Effects: Confirmed, Rare, and Conditions That Mimic Drug Reactions
Before concluding that liraglutide is causing your tinnitus, it helps to understand where different side effects stand on the evidence spectrum. The table below outlines key distinctions.
Side Effect or Condition |
Evidence Level |
Recommended Action |
|---|---|---|
Nausea, vomiting, diarrhea |
Well-established, common |
Manage with dietary changes; discuss with provider if severe |
Hypoglycemia (with other diabetes medications) |
Well-established, documented risk |
Monitor blood sugar; adjust medications with provider guidance |
Tinnitus linked to liraglutide |
Rare, unconfirmed causal link |
Document onset timing; consult provider and consider ENT evaluation |
Tinnitus from NSAIDs, diuretics, or certain antibiotics |
Well-established ototoxic drug class |
Review full medication list with provider or pharmacist |
Tinnitus from hypertension or type 2 diabetes |
Well-established independent risk |
Optimize management of underlying conditions |
Patulous Eustachian tube from rapid weight loss |
Plausible mechanism, underrecognized |
ENT evaluation if ear fullness or autophony accompanies tinnitus |
Most of liraglutide's documented side effects are gastrointestinal, nausea, vomiting, diarrhea, and constipation being the most frequently reported. These are very different from an auditory symptom, and distinguishing a drug reaction from an unrelated concurrent condition is one of the central challenges in clinical evaluation.
Why the Liraglutide Patient Population Is at Elevated Tinnitus Risk
This is where the picture becomes genuinely complicated. People who are prescribed liraglutide for weight management or type 2 diabetes tend to have several health conditions that independently raise tinnitus risk, even without any medication involvement.
Hypertension, which is common in this population, is a recognized contributor to tinnitus. Type 2 diabetes itself can affect small blood vessels and nerves in the ear over time, potentially leading to auditory changes. Obesity has also been associated with higher rates of both sensorineural hearing loss and tinnitus in epidemiological studies.
Beyond underlying conditions, many patients on liraglutide also take other medications. NSAIDs like ibuprofen, loop diuretics, and certain antibiotics are well-documented ototoxic agents, meaning they can directly harm auditory structures or exacerbate existing ear symptoms. Any evaluation of new tinnitus in someone on liraglutide needs to account for this broader medication landscape.
What to Do If You Notice Tinnitus While Taking Liraglutide
The most practical step you can take is to document when the tinnitus started relative to when you began liraglutide or had your dose increased. A clear temporal link, meaning tinnitus appeared within days to a few weeks of a medication change, is one of the strongest pieces of information a clinician can use when evaluating a possible drug reaction.
Do not stop taking liraglutide on your own. Abrupt discontinuation can affect blood sugar control and reverse progress with weight management. Your prescribing provider needs to be part of that decision. When you contact them, bring a list of all medications and supplements you are currently taking, so the full picture can be reviewed together.
An evaluation by an audiologist or ear, nose, and throat specialist can help rule out structural problems, ototoxic contributions from other medications, or conditions like Meniere's disease that require their own treatment approach. If your provider and the specialist agree that liraglutide is the most likely cause, they may consider a supervised trial off the medication to see whether the tinnitus resolves.
Finally, consider filing a MedWatch report with the FDA. Rare reactions only become visible in safety data when patients and providers report them. Contributing your experience helps researchers and regulators build a more complete picture of how liraglutide affects people across a wide range of circumstances.
Frequently Asked Questions
No. Tinnitus does not appear in the official prescribing information for Saxenda or Victoza as a common or well-established side effect. A small number of reports exist in the FDA's adverse event database, but the volume is low relative to total users, and a confirmed causal link has not been established at a population level.
Possibly. Rapid weight loss from any cause can sometimes affect Eustachian tube function, which may trigger or worsen tinnitus in certain individuals. If your tinnitus appeared alongside significant weight loss on liraglutide, that connection is worth discussing with your provider or an ENT specialist for a proper evaluation.
Timing is the most useful clue. If tinnitus began shortly after starting or increasing liraglutide, that pattern is worth noting. However, many medications taken alongside liraglutide, such as NSAIDs, certain antibiotics, and diuretics, are well-known ototoxic agents. An audiologist or ENT evaluation can help sort out the most likely cause.
Not without speaking to your provider first. Abrupt discontinuation of liraglutide can disrupt blood sugar control and weight management. Your prescriber can review your full medication list, assess the timing of your symptoms, and determine whether a trial pause or dose adjustment is appropriate alongside any needed hearing evaluation.
A small number of tinnitus reports appear in adverse event databases for other GLP-1 receptor agonists including semaglutide, but confirmed causal links have not been established for those medications either. Because GLP-1 receptors exist in inner ear tissue, researchers consider it a plausible class effect worth ongoing monitoring, though current evidence remains limited.
The Bottom Line
The connection between liraglutide and tinnitus is unconfirmed but not something to dismiss without a proper look. Patients taking Saxenda often have multiple independent risk factors for ear ringing, including hypertension and type 2 diabetes, which makes attribution genuinely complex. If you notice new or worsening tinnitus after starting liraglutide, you deserve a thorough evaluation rather than a quick assumption. Doctronic offers 24/7 AI consultations and affordable $39 video visits so you can quickly connect with a licensed clinician who can review your full medication list and symptom timeline. This article is informational and is not a medical diagnosis. Confirm with a licensed clinician, especially for new, worsening, or high-risk symptoms.
Related articles
Get medical advice
Chat Now